TherapeuticsMD, Inc.

$1.940
USD
Last updated on --.
24h volume128.86K
24h highest2.0200 USD
24h lowest1.9400 USD
24h Price movement-3.00%

TXMD recent prices

24 Hours
-3.00%-$0.06
30 days
-1.64%-$0.033
60 days
-2.13%-$0.043
90 days
-14.04%-$0.323

Key data

Previous close2.0000 USD
Market cap24.77M USD
Volume128.86K
P/E ratio138.380000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.020000 USD
Net income (FY)118.00K USD
Revenue (FY)3.35M USD
Last report dateMay 12, 2026

About TherapeuticsMD, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersBOCA RATON
Employees (FY)1.00
Revenue per employee (FY)3.35M USD
Net income per employee (FY)118.00K USD
Listed onNasdaq
Official website

TXMD conversion tables

TXMDTXMD
USDUSD
0.5 TXMD0.97 USD
1 TXMD1.940 USD
5 TXMD9.700 USD
10 TXMD19.4 USD
USDUSD
TXMDTXMD
0.5 USD0.25773 TXMD
1 USD0.51546 TXMD
5 USD2.577 TXMD
10 USD5.154 TXMD

FAQ

TXMD is trading at $1.940, -3.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TXMD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TXMD is currently trading at $1.940, -3.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TXMD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TXMD's P/E ratio is currently 138.380000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TXMD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TXMD's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
TherapeuticsMD, Inc.'s market cap is currently 24.77M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume128.86K
24h highest2.0200 USD
24h lowest1.9400 USD
24h Price movement-3.00%
TXMDTXMD
USDUSD
Start trade with TXMD Perpetual